The Biggest CBD-Infused Beverage Trends for 2019 and the Stocks Involved

Vancouver, British Columbia, CANADA

VANCOUVER, British Columbia, Jan. 23, 2019 (GLOBE NEWSWIRE) -- With the success of the 2018 Farm Bill in the rearview, investors are already setting their sights on what’s next: CBD-infused beverages.

CBD-infused coffee, tea, alkaline water, and probably any other digestible liquid that people can buy.

At this point, nothing’s off the table.

While the FDA insists that it maintains regulatory authority over CBD’s inclusion in food and drink products, the government agency’s increasingly lax stance towards CBD-infused products has already enabled a plethora of CBD-infused coffee, teas, and waters.

Meanwhile, North of the American border, Canadian coffee and tea brands are positioning themselves — directly or indirectly — to become leaders in the CBD-infused beverage space…

Major Coffee Retailers Explore Cannabis Opportunities

Second Cup (TSX: SCU) and National Access Cannabis (TSX-V: META) made waves back in September 2018 when they first announced their strategic alliance to convert select Second Cup locations into National Access Cannabis branded dispensaries.

While not exactly the sign of a marijuana coffee revolution, the potential for CBD-infused coffee has quietly grown into one of the cannabis industry’s most promising new product categories.

The rising popularity of CBD-infused coffee isn't just the anecdotal accounts of tourists trying out the latest New York coffee trends. In fact, it's headed for the mainstream: a CBD-infused coffee advertisement is expected to air during this year’s Super Bowl LIII.

The excitement surrounding CBD-infused coffee lies in the potential for a new functional drink; one that raises alertness levels without putting you on “edge”.

The jury, however, is still out on how exactly caffeine interacts with CBD. Some believe that caffeine cancels out the calming effect of CBD — while others argue that CBD’s mellowing effect dampens caffeine jitters.

Despite a limited body of scientific research, there appears to be at least some evidence supporting the benefits of a balanced CBD to caffeine ratio. 

According to Project CBD

"Low doses of CBD are unlikely to be affected by caffeine. But caffeine may counter the sedating effects of high doses of CBD."

But while the CBD-infused coffee market appears ready to blow, its caffeinated “older brother”, tea, has received little mainstream attention, despite having been discovered thousands of years before coffee.

CBD-Infused Premium Tea Market Remains In Limbo

Canadian-based DAVIDsTEA Inc. (NASDAQ: DTEA), a branded beverage company that offers a differentiated selection of proprietary loose-leaf teas, pre-packaged teas, tea sachets, and tea-related gifts in over 240 locations throughout North America, seemed like the likely candidate to lead the CBD-infused tea space.

So much so that even without any official announcement to explore CBD-infused beverages, DTEA surged over 63% on October 2, 2018 — just weeks before cannabis’ legalization in Canada. 

Unfortunately for shareholders, the uptrend was short-lived. Shares of DTEA have fallen almost 90% from US $14 since August 2016, and with Q3 fiscal 2018 financial results reporting a net loss of US $20.3 million for nine months ended November 3, 2018, any chance of a significant recovery is looking slim.

It’s no secret — what DAVIDsTEA requires is a return to form.

In an earlier earnings call back in September 2018, DAVIDsTEA executive chairman and interim CEO Herschel Segal was quoted saying,

“Following a thorough evaluation, we determined that we need to get back to the basics of product innovation and procurement . . .

While a CBD-infused product line may not be the cure-all for DAVIDsTEA’s problems, it may be exactly the kind of product innovation that its customers are waiting for.

CBD-Infused Alkaline Water Segment Dominates

One can hardly forget the world’s most popular drink: water.

As mentioned earlier, though the FDA still technically prohibits the sale of CBD-infused food and drink products, the passing of the 2018 Farm Bill has signaled what some consider to be a relaxing of the FDA’s stance on CBD.

The perception of this relaxed stance has encouraged a number of companies to begin selling CBD-infused water products around the world — both online and in retail stores.

Youngevity International Inc. (NASDAQ: YGYI) is an example of one such company. 

Youngevity is an omni-direct lifestyle branding company that manages a portfolio of wellness products, including everything from chocolate and vitamin supplements to makeup and soy candles. 

Last October, Youngevity added a selection of CBD oils to their roster of nutritional products under the brand name “Hemp FX”. 

In follow-up to the addition of a CBD oil product line, Youngevity recently announced a cross-marketing agreement with Icelandic Glacial, an award-winning bottled water company that sells a variety of 8.4 pH alkaline water products sourced from Iceland’s prestigious Ölfus Spring. The agreement stipulates that the two companies will work together to develop and sell new products—with CBD-infused drinks at the forefront of the new partnership’s product development pipeline.

Then there's the current alkaline water powerhouse and the fastest premium growing water brand in the U.S...

The Alkaline Water Company (NASDAQ: WTER) and (TSXV: WTER), a leading producer of premium bottled alkaline drinking water sold under the brand name Alkaline88®, is another company vying for the alkaline water “throne”.

In fact, it's already the fastest growing alkaline water company and the fastest growing premium water brand in the U.S.

Alkaline88® is now sold in over 47,500 retail locations nationwide in all 50 states, with a distribution that spans more than 150,000 stores, including 9 of the top 10 largest retailers in the entire U.S. and two of the largest retailers in the entire world.

And by combining a state-of-the-art, proprietary electrolysis beverage process with unique brand positioning, the Alkaline Water Company is shaping up to be a top contender in the CBD-infused beverage space.

Last year, the Alkaline Water Company announced a whole new line of products in the healthful water category – the fastest growing beverage category in the world.

This includes Alkaline88® infused with Natural Vitamins and Minerals, Natural Sparkling Alkaline88® water, and Naturally Flavored Alkaline88® water.

Most importantly, it will use its Alkaline88® platform to launch a hemp-infused Alkaline88® water.

While the Alkaline Water Company won’t sell any of its previously announced CBD-infused alkaline water products until it obtains all of the legal permits required to do so (FDA and otherwise), the company has recently partnered with Water Source One, a leading producer and supplier of branded and private label bottled water products in the United States, to support the national expansion of the Alkaline 88 brand across the United States. By partnering with Water Source One, the Alkaline Water Company is able to lower shipping costs, scale production, and work alongside beverage industry veterans—many of whom came from major beverage companies such as Nestle and Coca-Cola.

In addition, it has already secured a deal that brings a patent-pending process that can bring true water-soluble, full-spectrum features of bioactive natural hemp extract molecules to U.S. consumers.

Via Alkaline Water Company:

“The Alkaline Water Company Inc. has entered into a Binding Letter of Agreement with Infusion Biosciences, Inc., that provides a non-exclusive license to utilize its proprietary Aqueous Phytorecovery Process (“APP”) technology.

Under the Agreement, IBS agreed to provide A88 Infused with ready-to-drink natural hemp-extract formulations.”

With APP’s formulations, A88 Infused is expected to be the first national U.S. beverage company– and the first NASDAQ-listed company – to bring true water-soluble, full-spectrum features of bioactive natural hemp extract molecules to U.S. consumers.

Strong, complimentary partnerships play a vital role in the success or failure of brand expansions, and the alkaline water space is no different.

CBD Drives Beverage Innovation

If there’s a common thread that ties the success of beverage companies together, it’s product innovation. 

The problem with innovation is that it’s rarely easy; it often requires significant resources, be it time or capital. For these reasons and more, expect industry leaders to lean on newer, niche companies in the cannabis space — a la Second Cup and National Access Cannabis — to derisk their marijuana expansion efforts. Moreover, the growth of the CBD-infused alkaline water product segment is likely to provide investors with further opportunities throughout the year, especially as the FDA provides more clarification around the future of CBD-infused products.

Disclosure: Directors of Mugglehead own shares of Alkaline Water.

The original post can be found here:

Directors of Mugglehead own shares of Alkaline Water (WTER) at the time of this writing.

About Mugglehead is a digital publisher dedicated to cannabis news, investments, culture, and science, owned by Mugglehead Media Corp. We publish original content, including video, interviews and articles. Because many of the companies and trends we cover are related to investments and stocks within the cannabis industry, please review our disclaimer and forward-looking statements below.

Original content created by Mugglehead Media Corp. © 2019 is protected by copyright laws.

We have lots in store for 2019 so be sure to check us out!

Visit us at daily for all things cannabis-related.



Disclaimer and Forward-Looking Statements

Mugglehead Media Corp. and (collectively, Mugglehead) is a news and media publisher dedicated to cannabis. It is not registered as an investment adviser, broker-dealer or other financial or securities professional with any financial or securities regulatory authority. You understand that no content published by Mugglehead constitutes a recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Mugglehead does not render general or specific investment advice and does not endorse or recommend the business, products, services or securities of any industry or company mentioned on this Site.

It is not intended to provide tax, legal, insurance or investment advice, and nothing on the Site should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation to buy or sell any security. None of the content we publish is provided with a view to inviting, inducing or encouraging any person to make any kind of investment decision. You are solely responsible for determining whether any investment, security or strategy, or any other product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation. You should consult an attorney or tax professional regarding your specific legal or tax situation. You should also consult a licensed professional, such as a financial advisor or broker-dealer, when dealing in any securities or making any investment decisions. We do not guarantee that any of the companies mentioned on or any of our newsletters or content will perform as we expect, and any comparisons we have made to other companies may not be valid or come into effect.

This news release is not an offer to sell or a solicitation of an offer to buy any securities or commodities. To the extent that anything in this press release may be deemed to be investment advice or a recommendation in connection with a particular company or security, such information is impersonal and is not tailored to the needs of any specific person.

You understand that an investment in any security is subject to a number of risks, and that discussions of any security published on the Site will not contain a list or description of relevant risk factors. In addition, some of the securities about which content is published by us have a low market capitalization, insufficient public float and/or are thinly traded. Such securities are subject to more risk than securities of larger companies, including greater volatility, lower liquidity and less publicly available information. Content we publish may have an effect on the price of such securities.

From time to time, Mugglehead (on behalf of itself and any partner, director, officer or insider of Mugglehead) may have a financial or other interest in the party or parties featured on the Site, within the meaning of National Instrument 31-103 - Registration Requirements, Exemptions, and Ongoing Registrant Obligations, published by the Canadian Securities Administrators, as a result of ownership of securities in, compensation received or receivable from or other financial arrangement with such party or parties featured in this press release. We will disclose if we have a position in any such party or parties, as at the date of publication of this press release; however, we may not update this disclosure after such date. Directors of Mugglehead own shares of Alkaline Water (WTER) at the time of this writing.

In addition to historical information, this press release may contain forward-looking statements, including statements with respect to third parties regarding product plans, future growth, market opportunities, strategic initiatives, industry positioning, customer acquisition, the amount of recurring revenue and revenue growth. In addition, when used on the Site, the words ''will,'' ''expects,'' ''could,'' ''would,'' ''may,'' ''anticipates,'' ''intends,'' ''plans,'' ''believes,'' ''seeks,'' ''targets,'' ''estimates,'' ''looks for,'' ''looks to,'' ''continues'' and similar expressions, as well as statements regarding a third party's focus for the future, are generally intended to identify forward-looking statements. Each of the forward-looking statements we make in this press release involves risks and uncertainties that may cause actual results to differ materially from these forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those disclosed by the companies featured in this release in their public securities filings. You should carefully review the risks described therein. You should not place undue reliance on these forward-looking statements, which speak only as of the date such statement was published. Mugglehead undertakes no obligation to publicly release any updates or revisions to the forward-looking statements or reflect events or circumstances after the date of their publication, except as required by law.

From time to time, reference may be made in this press release to prior articles or opinions we have published. These references may be selective, may reference only a portion of an article or opinion, and are likely not to be current. As market information changes continuously, previously published information and data, and any references thereto, may not be current and should not be relied upon.

If you ever have any questions or concerns about our business or publications, we encourage you to contact us.


Contact Data